ATARA BIOTHERAPEUTICS, INC. Retained Earnings
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Retained Earnings of -$2.03 billion as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$2.03B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$2.03B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$2.02B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$2.02B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$2.03B 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$2.03B 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$2.02B 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$2.02B 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$2.01B 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$2.02B 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$2.05B 10-K · filed 2026-03-16 |
| 2024-09-30 | -$2.04B 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$2.02B 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$2.00B 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$1.97B 10-K · filed 2025-03-07 |
| 2023-09-30 | -$1.91B 10-Q · filed 2023-11-01 |
| 2023-06-30 | -$1.84B 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$1.77B 10-Q · filed 2023-05-08 |
| 2022-12-31 | -$1.69B 10-K · filed 2024-03-28 |
| 2022-09-30 | -$1.62B 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.53B 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$1.55B 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$1.46B 10-K · filed 2023-02-08 |
| 2021-09-30 | -$1.37B 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$1.29B 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$1.20B 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$1.12B 10-K · filed 2022-02-28 |
| 2020-09-30 | -$1.04B 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$968.93M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$891.47M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$817.96M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$739.47M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$667.57M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$593.24M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$527.35M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$447.34M 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$388.98M 10-Q · filed 2018-08-01 |
| 2018-03-31 | -$338.09M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$296.65M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$261.34M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$230.24M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$202.81M 10-Q · filed 2017-05-04 |
| 2016-12-31 | -$177.16M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$158.92M 10-Q · filed 2016-11-04 |
| 2016-06-30 | -$133.55M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$114.67M 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$98.11M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$76.86M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$64.99M 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$50.05M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$40.89M 10-K · filed 2016-03-04 |
| 2014-09-30 | -$30.36M 10-Q · filed 2014-11-12 |
| 2013-12-31 | -$12.88M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |